{"id":55391,"date":"2025-01-21T07:58:33","date_gmt":"2025-01-21T08:58:33","guid":{"rendered":"https:\/\/peymantaeidi.net\/stem-cell\/?p=55391"},"modified":"2025-01-21T09:37:21","modified_gmt":"2025-01-21T09:37:21","slug":"neurobots-could-help-treat-epilepsy","status":"publish","type":"post","link":"https:\/\/peymantaeidi.net\/stem-cell\/2025\/01\/21\/neurobots-could-help-treat-epilepsy\/","title":{"rendered":"Neurobots could help treat epilepsy"},"content":{"rendered":"<div><\/div>\n<p>Project NEUROBOT is one of 18 sharing \u00a369m over four years in new funding announced yesterday (January 20, 225) from <a href=\"https:\/\/www.aria.org.uk\/opportunity-spaces\/scalable-neural-interfaces\/precision-neurotechnologies\">ARIA\u2019s Precision Neurotechnologies programme<\/a>.<\/p>\n<p>The NEUROBOT team will work to develop advanced, injectable neural robots, or \u2018neurobots\u2019, to deliver a treatment called closed-loop neuromodulation as an epilepsy treatment.<\/p>\n<p>Closed-loop neuromodulation works by closely monitoring brain activity and providing electrical stimulation when required to help treat epileptic seizures as they occur, or prevent them from happening at all.<\/p>\n<p>Made from advanced nanomaterials, the neurobots will provide precisely-targeted neural stimulation, as well as deliver drugs to patients through newly-developed bioactive coatings and encapsulants.<\/p>\n<p><a href=\"https:\/\/www.theengineer.co.uk\/medical-healthcare\">MORE FROM MEDICAL &amp; HEALTHCARE<\/a><\/p>\n<p>This technology is claimed to address the limitations of traditional deep brain recording and stimulation using electrodes implanted in brain tissue, which can disrupt normal brain function and cause side effects.<\/p>\n<p>The team\u2019s broader vision is to revolutionise neuromodulation therapies by using innovative materials and AI-driven control to create individualised, minimally-invasive adaptive treatments that enhance therapeutic outcomes.<\/p>\n<p>The project will be led by Professor Hadi Heidari at Glasgow\u2019s James Watt School of Engineering with support from the Universities of Exeter, Manchester and Newcastle in the UK and the Istituto Italiano di Tecnologia (IIT) in Italy. NEUROBITE Technologies, a startup spun out from Glasgow University by PhD student Maria Cerezo-Sanchez, is also lending support to the project.<\/p>\n<p>\u201cWe\u2019re pleased and proud to have received this funding from ARIA\u2019s Precision Neurotechnologies programme,\u201d Professor Heidari said in a statement. \u201cIt will enable us to build on previous breakthrough research collaborations between the partners on the potential for neurobots to treat epilepsy more effectively and less invasively.\u201d<\/p>\n<p>He continued: \u201cOur team comprises experts from a diverse range of fields, including nanotechnology, neurobiology, and biomedical engineering, with backgrounds in developing advanced microelectronics, neuromodulation techniques, and biocompatible materials. Each partner brings unique expertise, ensuring a comprehensive approach to the NEUROBOT project and enhancing our capacity for successful research and development in precision neuromodulation therapies.\u201d<\/p>\n<p>In the UK, one in six people \u2013 16.5 million individuals \u2013 has at least one neurological condition, with a cost to the NHS of \u00a34.4bn per year. The conditions also include Alzheimer\u2019s, epilepsy, addiction, and depression. Many of these are neural circuit-level disorders, or problems with the \u2018wiring\u2019 of the brain, but current technologies lack the requisite precision and most are highly invasive.<\/p>\n<p>The researchers will explore and unlock new methods to interface with the human brain at the circuit level, in order to understand, identify, and treat neurological and neuropsychiatric disorders with \u2018unprecedented precision\u2019.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Project NEUROBOT is one of 18 sharing \u00a369m over four years in new funding announced<\/p>\n","protected":false},"author":1,"featured_media":55393,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/55391"}],"collection":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/comments?post=55391"}],"version-history":[{"count":2,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/55391\/revisions"}],"predecessor-version":[{"id":55394,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/55391\/revisions\/55394"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/media\/55393"}],"wp:attachment":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/media?parent=55391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/categories?post=55391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/tags?post=55391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}